0001437749-23-034227.txt : 20231212
0001437749-23-034227.hdr.sgml : 20231212
20231212170517
ACCESSION NUMBER: 0001437749-23-034227
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231208
FILED AS OF DATE: 20231212
DATE AS OF CHANGE: 20231212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LeMaitre George W
CENTRAL INDEX KEY: 0001365737
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33092
FILM NUMBER: 231481949
MAIL ADDRESS:
STREET 1: 342 BUNKER HILL STREET, #2B
CITY: CHARLESTOWN
STATE: MA
ZIP: 02129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC
CENTRAL INDEX KEY: 0001158895
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-221-2266
MAIL ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-12-08
0001158895
LEMAITRE VASCULAR INC
LMAT
0001365737
LeMaitre George W
C/O LEMAITRE VASCULAR, INC.
63 SECOND AVENUE
BURLINGTON
MA
01803
1
1
1
Chairman and CEO
0
Common Stock
2023-12-11
4
S
0
22088
54.41
D
2269675
D
Common Stock
2023-12-11
4
S
0
200
54.99
D
2269475
D
Common Stock
2023-12-08
4
A
0
5032
0
A
2291763
D
Stock Option (Right to Buy)
54.65
2023-12-08
4
A
0
26555
0
A
2023-12-08
2030-12-08
Common Stock
26555
26555
D
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $53.94 to $54.79. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $54.96 to $55.03. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.
The exercise price of this option to the extent it is an incentive stock option is $60.12 per share, and the exercise price of this option to the extent it is a nonqualified stock option is $54.65 per share.
This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.
The expiration date of this option to the extent it is an incentive stock option is 12/8/2028, and the expiration date of this option to the extent it is a nonqualified stock option is 12/8/2030.
/s/ David .Hissong
2023-12-12